October 29, 2012

ProPhase Labs on Monday again rejected an acquisition proposal from Matrixx Initiatives. Matrixx's latest offer was to acquire ProPhase for $1.60 per share in cash, up from a prior $1.40 per share proposal.

October 9, 2012

Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share.

May 11, 2012

The lackluster cough-cold season will necessitate a greater need for marketing and promotion next season, ProPhase Labs chairman and CEO Ted Karkus said on Thursday in announcing first-quarter results for the period ended March 31.

January 27, 2012

ProPhase Labs on Thursday named the October, November and December winners of its "Share Your Cause Not Your Cold" campaign.

November 28, 2011

ProPhase Labs on Monday partnered with Give2TheTroops to aid in the combat against the common cold this holiday season.

November 18, 2011

ProPhase Labs on Thursday announced that its Cold-Eeze product has been awarded the Parent Tested, Parent Approved Winner's Seal of Approval.

November 1, 2011

ProPhase Labs on Tuesday launched the Cold-Eeze oral spray, which is formulated with zinc gluconate to help reduce the severity and duration of the common cold.

March 4, 2011

DOYLESTOWN, Pa. — ProPhase Labs last month created a Facebook personality quiz to benefit the American Heart Association. For each Facebook fan who takes the “What’s Your Cold-Eeze Flavor?” personality quiz, ProPhase will donate $1 to the AHA, up to a total of $2,500.

September 6, 2010

ProPhase Labs on Tuesday announced it has retained media solutions company Women's Marketing as its...